LECTURE

Chairman: P.L. Zinzani

Clonal evolution in myeloid neoplasms and inflammatory stromal remodeling: implications for immunotherapy
M.H.G.P. Raaijmakers
SESSION 1 INSIDE OUT: HOW CELL-INTRINSIC FEATURES OUTBREAK AML IMMUNE MICROENVIRONMENT

Chairman: A. Curti

Leukemia epigenetic remodelling: the lesson of allogeneic stem cell transplantation
L.A.E. Vago
Epithelial-to-mesenchymal transition
S. Sangaletti
SESSION 2 WHICH ARE THE HALLMARKS OF AML IMMUNE MICROENVIRONMENT?

Chairmen: A. Curti, S. Rutella

Bone marrow immune cells aggregation
O. Heidenreich
SESSION 3 SO WHAT? HOW TO MOVE A STEP FORWARD INTO THE CLINICS

Chairman: A. Curti

Dendritic cell immunotherapy in myeloid leukemia
B. Gjertsen
AML-directed CAR-T cell therapies: where we stand
S.M. Subklewe
Menin inhibition: immunological effects and implications for future immunotherapies - NPM1 and immune microenvironment
M.P. Martelli
Menin inhibition: immunological effects and implications for future immunotherapies - Menin inhibitors
C. Papayannidis
Privacy Policy | Cookie Policy